BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lou G, Chen L, Xia C, Wang W, Qi J, Li A, Zhao L, Chen Z, Zheng M, Liu Y. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. J Exp Clin Cancer Res. 2020;39:4. [PMID: 31898515 DOI: 10.1186/s13046-019-1512-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Xia H, Huang Z, Liu S, Zhao X, He R, Wang Z, Shi W, Chen W, Li Z, Yu L, Huang P, Kang P, Su Z, Xu Y, Yam JWP, Cui Y. Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma. Front Oncol 2021;11:653846. [PMID: 33869059 DOI: 10.3389/fonc.2021.653846] [Reference Citation Analysis]
2 Massey AE, Malik S, Sikander M, Doxtater KA, Tripathi MK, Khan S, Yallapu MM, Jaggi M, Chauhan SC, Hafeez BB. Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment. Int J Mol Sci 2021;22:5278. [PMID: 34067896 DOI: 10.3390/ijms22105278] [Reference Citation Analysis]
3 Sorop A, Constantinescu D, Cojocaru F, Dinischiotu A, Cucu D, Dima SO. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma. Int J Mol Sci 2021;22:4997. [PMID: 34066780 DOI: 10.3390/ijms22094997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zhao K, Li X, Shi Y, Lu Y, Qiu P, Deng Z, Yao W, Wang J. Exosomes in the tumor microenvironment of cholangiocarcinoma: current status and future perspectives. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03294-x] [Reference Citation Analysis]
5 Wei Y, Li N, Zhao L, Yang C, Ma B, Li X, Wei R, Nian H. MicroRNAs and Autoimmune-Mediated Eye Diseases. Front Cell Dev Biol 2020;8:818. [PMID: 32974350 DOI: 10.3389/fcell.2020.00818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Jia W, Liang S, Cheng B, Ling C. The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment. Front Oncol 2021;11:763519. [PMID: 34868982 DOI: 10.3389/fonc.2021.763519] [Reference Citation Analysis]
7 Driscoll J, Wehrkamp C, Ota Y, Thomas JN, Yan IK, Patel T. Biological Nanotherapeutics for Liver Disease. Hepatology 2021;74:2863-75. [PMID: 33825210 DOI: 10.1002/hep.31847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
8 Li J, Yao Z, Xiong H, Cui H, Wang X, Zheng W, Qian Y, Fan C. Extracellular vesicles from hydroxycamptothecin primed umbilical cord stem cells enhance anti-adhesion potential for treatment of tendon injury. Stem Cell Res Ther 2020;11:500. [PMID: 33239069 DOI: 10.1186/s13287-020-02016-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, LeBleu VS, McAndrews KM, Kalluri R. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J 2021;35:e21557. [PMID: 33855751 DOI: 10.1096/fj.202002777RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Sun Y, Liu G, Zhang K, Cao Q, Liu T, Li J. Mesenchymal stem cells-derived exosomes for drug delivery. Stem Cell Res Ther 2021;12:561. [PMID: 34717769 DOI: 10.1186/s13287-021-02629-7] [Reference Citation Analysis]
11 Chen X, Chi H, Zhao X, Pan R, Wei Y, Han Y, Granito A. Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2521025] [Reference Citation Analysis]
12 Hu F, Liu J, Liu H, Li F, Wan M, Zhang M, Jiang Y, Rao M. Role of Exosomal Non-coding RNAs in Gastric Cancer: Biological Functions and Potential Clinical Applications. Front Oncol 2021;11:700168. [PMID: 34195097 DOI: 10.3389/fonc.2021.700168] [Reference Citation Analysis]
13 Yassine S, Alaaeddine N. Mesenchymal Stem Cell Exosomes and Cancer: Controversies and Prospects. Adv Biol (Weinh) 2021;:e2101050. [PMID: 34939371 DOI: 10.1002/adbi.202101050] [Reference Citation Analysis]
14 Araujo-Abad S, Saceda M, de Juan Romero C. Biomedical application of small extracellular vesicles in cancer treatment. Adv Drug Deliv Rev 2022;182:114117. [PMID: 35065142 DOI: 10.1016/j.addr.2022.114117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Vicinanza C, Lombardi E, Ros FD, Marangon M, Durante C, Mazzucato M, Agostini F. Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications. WJSC 2022;14:54-75. [DOI: 10.4252/wjsc.v14.i1.54] [Reference Citation Analysis]
16 Semaan L, Zeng Q, Lu Y, Zhang Y, Zreik MM, Chamseddine MB, Chopp M, Zhang ZG, Moonka D. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs. Oncotarget 2021;12:185-98. [PMID: 33613846 DOI: 10.18632/oncotarget.27879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Zheng Q, Zhang S, Guo WZ, Li XK. The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation. Front Immunol 2021;12:659621. [PMID: 33889158 DOI: 10.3389/fimmu.2021.659621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Xu HK, Chen LJ, Zhou SN, Li YF, Xiang C. Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases. World J Stem Cells 2020; 12(11): 1276-1294 [PMID: 33312398 DOI: 10.4252/wjsc.v12.i11.1276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol 2021;14:136. [PMID: 34479611 DOI: 10.1186/s13045-021-01141-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang X, Li N, Zhu Y, Wen W. The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma. Cancer Med 2022. [PMID: 34981659 DOI: 10.1002/cam4.4521] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Tian C, Yang Y, Bai B, Wang S, Liu M, Sun RC, Yu T, Chu XM. Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity. Int J Biol Sci 2021;17:1328-38. [PMID: 33867849 DOI: 10.7150/ijbs.58786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
22 Torki Z, Ghavi D, Hashemi S, Rahmati Y, Rahmanpour D, Pornour M, Alivand MR. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update. Cancer Chemother Pharmacol 2021;88:771-93. [PMID: 34510251 DOI: 10.1007/s00280-021-04337-8] [Reference Citation Analysis]
23 Chen W, Mao Y, Liu C, Wu H, Chen S. Exosome in Hepatocellular Carcinoma: an update. J Cancer 2021;12:2526-36. [PMID: 33854614 DOI: 10.7150/jca.54566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ortega A, Martinez-Arroyo O, Forner MJ, Cortes R. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus. Pharmaceutics 2020;13:E3. [PMID: 33374908 DOI: 10.3390/pharmaceutics13010003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
25 Sinha D, Roy S, Saha P, Chatterjee N, Bishayee A. Trends in Research on Exosomes in Cancer Progression and Anticancer Therapy. Cancers (Basel) 2021;13:326. [PMID: 33477340 DOI: 10.3390/cancers13020326] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
26 Schulz-Siegmund M, Aigner A. Nucleic acid delivery with extracellular vesicles. Adv Drug Deliv Rev 2021;173:89-111. [PMID: 33746014 DOI: 10.1016/j.addr.2021.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
27 Li A, Zhao Y, Li Y, Jiang L, Gu Y, Liu J. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles. Drug Deliv 2021;28:1237-55. [PMID: 34142930 DOI: 10.1080/10717544.2021.1938757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Roy B, Ghose S, Biswas S. Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma. Semin Cell Dev Biol 2021:S1084-9521(21)00079-3. [PMID: 33926792 DOI: 10.1016/j.semcdb.2021.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Liu M, Cao Y, Hu Y, Zhang Z, Ji S, Shi L, Tao G. MiR-199a-3p Restrains Foaming and Inflammation by Regulating RUNX1 in Macrophages. Mol Biotechnol. [DOI: 10.1007/s12033-022-00484-2] [Reference Citation Analysis]
30 Rios-Colon L, Arthur E, Niture S, Qi Q, Moore JT, Kumar D. The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells. Cells 2020;9:E1988. [PMID: 32872417 DOI: 10.3390/cells9091988] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
31 Fu P, Zhang J, Li H, Mak M, Xu W, Tao Z. Extracellular vesicles as delivery systems at nano-/micro-scale. Adv Drug Deliv Rev 2021;179:113910. [PMID: 34358539 DOI: 10.1016/j.addr.2021.113910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
32 Jiang Y, Li J, Xue X, Yin Z, Xu K, Su J. Engineered extracellular vesicles for bone therapy. Nano Today 2022;44:101487. [DOI: 10.1016/j.nantod.2022.101487] [Reference Citation Analysis]
33 Tang Y, Wu P, Li L, Xu W, Jiang J. Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases. Front Immunol 2022;13:880523. [DOI: 10.3389/fimmu.2022.880523] [Reference Citation Analysis]
34 Zhao R, Zhao T, He Z, Cai R, Pang W. Composition, isolation, identification and function of adipose tissue-derived exosomes. Adipocyte 2021;10:587-604. [PMID: 34709975 DOI: 10.1080/21623945.2021.1983242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Cheng T, Ding S, Liu S, Li Y, Sun L. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis. Theranostics 2021;11:893-905. [PMID: 33391511 DOI: 10.7150/thno.48080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
36 Gu H, Yan C, Wan H, Wu L, Liu J, Zhu Z, Gao D. Mesenchymal stem cell-derived exosomes block malignant behaviors of hepatocellular carcinoma stem cells through a lncRNA C5orf66-AS1/microRNA-127-3p/DUSP1/ERK axis. Hum Cell 2021;34:1812-29. [PMID: 34431063 DOI: 10.1007/s13577-021-00599-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Li S, Shao J, Lou G, Wu C, Liu Y, Zheng M. MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway. J Exp Clin Cancer Res 2021;40:53. [PMID: 33526055 DOI: 10.1186/s13046-021-01853-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ghafouri-Fard S, Honarmand Tamizkar K, Hussen BM, Taheri M. MicroRNA signature in liver cancer. Pathol Res Pract 2021;219:153369. [PMID: 33626406 DOI: 10.1016/j.prp.2021.153369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Patil SM, Sawant SS, Kunda NK. Exosomes as drug delivery systems: A brief overview and progress update. Eur J Pharm Biopharm 2020;154:259-69. [PMID: 32717385 DOI: 10.1016/j.ejpb.2020.07.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
40 Zhao LX, Zhang K, Shen BB, Li JN. Mesenchymal stem cell-derived exosomes for gastrointestinal cancer. World J Gastrointest Oncol 2021; 13(12): 1981-1996 [DOI: 10.4251/wjgo.v13.i12.1981] [Reference Citation Analysis]
41 Jia Z, Zhu H, Sun H, Hua Y, Zhang G, Jiang J, Wang X. Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling. Cancer Manag Res 2020;12:8733-44. [PMID: 33061571 DOI: 10.2147/CMAR.S270200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Nasrollahzadeh Sabet M, Movahedi Asl M, Kazemi Esfeh M, Nasrabadi N, Shakarami M, Alani B, Alimolaie A, Azhdari S, Cheraghi E. Mesenchymal stem cells as professional actors in gastrointestinal cancer therapy: From Naïve to genetically modified. Iran J Basic Med Sci 2021;24:561-76. [PMID: 34249257 DOI: 10.22038/ijbms.2021.54735.12277] [Reference Citation Analysis]
43 Cai X, Qu L, Yang J, Xu J, Sun L, Wei X, Qu X, Bai T, Guo Z, Zhu Y. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1. Cancer Med 2020;9:6009-19. [PMID: 32627968 DOI: 10.1002/cam4.3263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
44 Psaraki A, Ntari L, Karakostas C, Korrou-Karava D, Roubelakis MG. Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseases. Hepatology 2022;75:1590-603. [PMID: 34449901 DOI: 10.1002/hep.32129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
45 Liu YR, Cheng YQ, Wang SB, Su YR, Liu Y, Li CY, Jin L, Wan Q, Sang X, Wang ZC. Therapeutic effects and perspective of stem cell extracellular vesicles in aging and cancer. J Cell Physiol 2021;236:4783-96. [PMID: 33368322 DOI: 10.1002/jcp.30212] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Deng L, Wang C, He C, Chen L. Bone mesenchymal stem cells derived extracellular vesicles promote TRAIL-related apoptosis of hepatocellular carcinoma cells via the delivery of microRNA-20a-3p. Cancer Biomark 2021;30:223-35. [PMID: 33136092 DOI: 10.3233/CBM-201633] [Reference Citation Analysis]
47 Wang T, Fu Y, Sun S, Huang C, Yi Y, Wang J, Deng Y, Wu M. Exosome-based drug delivery systems in cancer therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.05.022] [Reference Citation Analysis]
48 Liu L, DU C, Wei X, Liao R. [Correlation of peritumoral circWDR25 expression with the prognosis of patients with hepatocellular carcinoma after curative resection]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1388-93. [PMID: 34658354 DOI: 10.12122/j.issn.1673-4254.2021.09.14] [Reference Citation Analysis]
49 Zhang R, Tu J, Liu S. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity. Semin Cancer Biol 2021:S1044-579X(21)00058-4. [PMID: 33737107 DOI: 10.1016/j.semcancer.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Yao L, Zhang W, Zheng J, Lu X, Zhang F. miR-199a Targeting PNRC1 to Promote Keratinocyte Proliferation and Invasion in Cholesteatoma. Biomed Res Int 2021;2021:1442093. [PMID: 34825000 DOI: 10.1155/2021/1442093] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Song N, Scholtemeijer M, Shah K. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Trends Pharmacol Sci 2020;41:653-64. [PMID: 32709406 DOI: 10.1016/j.tips.2020.06.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 18.0] [Reference Citation Analysis]
52 Sritharan S, Guha S, Hazarika S, Sivalingam N. Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance. Apoptosis 2022. [PMID: 35716277 DOI: 10.1007/s10495-022-01742-z] [Reference Citation Analysis]
53 de Jong B, Barros ER, Hoenderop JGJ, Rigalli JP. Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine. Pharmaceutics 2020;12:E1006. [PMID: 33105857 DOI: 10.3390/pharmaceutics12111006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
54 Mondal P, Kaur B, Natesh J, Meeran SM. The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications. Semin Cell Dev Biol 2021:S1084-9521(21)00074-4. [PMID: 33865701 DOI: 10.1016/j.semcdb.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Siddaiah R, Emery L, Stephens H, Donnelly A, Erkinger J, Wisecup K, Hicks SD, Kawasawa YI, Oji-mmuo C, Amatya S, Silveyra P. Early Salivary miRNA Expression in Extreme Low Gestational Age Newborns. Life 2022;12:506. [DOI: 10.3390/life12040506] [Reference Citation Analysis]
56 Hong P, Yu M, Tian W. Diverse RNAs in adipose-derived extracellular vesicles and their therapeutic potential. Mol Ther Nucleic Acids 2021;26:665-77. [PMID: 34703651 DOI: 10.1016/j.omtn.2021.08.028] [Reference Citation Analysis]
57 Sun C, Shi C, Duan X, Zhang Y, Wang B. Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4. Bioengineered 2022;13:5915-27. [PMID: 35199612 DOI: 10.1080/21655979.2021.2023799] [Reference Citation Analysis]
58 Nasser MI, Masood M, Adlat S, Gang D, Zhu S, Li G, Li N, Chen J, Zhu P. Mesenchymal stem cell-derived exosome microRNA as therapy for cardiac ischemic injury. Biomed Pharmacother 2021;143:112118. [PMID: 34481378 DOI: 10.1016/j.biopha.2021.112118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Meldolesi J. Cancer Stem Cells and Their Vesicles, Together with Other Stem and Non-Stem Cells, Govern Critical Cancer Processes: Perspectives for Medical Development. Int J Mol Sci 2022;23:625. [PMID: 35054811 DOI: 10.3390/ijms23020625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Wang H, Wang X, Liu X, Zhou J, Yang Q, Chai B, Chai Y, Ma Z, Lu S, Srivastava S. miR-199a-5p Plays a Pivotal Role on Wound Healing via Suppressing VEGFA and ROCK1 in Diabetic Ulcer Foot. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/4791059] [Reference Citation Analysis]
61 Escudé Martinez de Castilla P, Tong L, Huang C, Sofias AM, Pastorin G, Chen X, Storm G, Schiffelers RM, Wang JW. Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies. Adv Drug Deliv Rev 2021;175:113801. [PMID: 34015418 DOI: 10.1016/j.addr.2021.05.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
62 Zhang F, Guo J, Zhang Z, Qian Y, Wang G, Duan M, Zhao H, Yang Z, Jiang X. Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy. Cancer Lett 2021;526:29-40. [PMID: 34800567 DOI: 10.1016/j.canlet.2021.11.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
63 Guo M, Li N, Zheng J, Wang W, Wu Y, Han X, Guo J, Chen W, Bai Z, Bai W, Wu J. Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway. Can J Gastroenterol Hepatol 2021;2021:5596712. [PMID: 34123955 DOI: 10.1155/2021/5596712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Song S, Zhang Y, Ding T, Ji N, Zhao H. The Dual Role of Macropinocytosis in Cancers: Promoting Growth and Inducing Methuosis to Participate in Anticancer Therapies as Targets. Front Oncol 2020;10:570108. [PMID: 33542897 DOI: 10.3389/fonc.2020.570108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Sanmartin MC, Borzone FR, Giorello MB, Yannarelli G, Chasseing NA. Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy. Front Bioeng Biotechnol 2022;10:882545. [DOI: 10.3389/fbioe.2022.882545] [Reference Citation Analysis]
66 Moldogazieva NT, Zavadskiy SP, Terentiev AA. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine. Cancer Genomics Proteomics 2021;18:369-83. [PMID: 33994362 DOI: 10.21873/cgp.20266] [Reference Citation Analysis]